← SearchINVARIANCE MAPPING OF THE COMPLETE HBV GENOME AND TESTING OF MRE11 REPAIR NUCLEASE TOWARD THE IMPROVEMENT OF CRISPR/CAS THERAPY FOR HEPATITIS B$1,878,970FY2022Department of the ArmyDODInvvax, Inc., Cypress InvestigatorsView source on USAspending →